Tongjitang Chinese Medicines Company to Announce First Quarter 2009 Financial Results on June 3, 2009
* Reuters is not responsible for the content in this press release.
SHENZHEN, China--(Business Wire)--
Tongjitang Chinese Medicines Company (NYSE: TCM) ("Tongjitang" or the
"Company"), a leading specialty pharmaceutical company focusing on the
development, manufacturing, marketing and selling of modernized traditional
Chinese medicine ("TCM") in China, today announced that it plans to announce its
first quarter 2009 financial results before the market opens on Wednesday, June
3, 2009.
Tongjitang`s management team will hold a conference call on June 3, 2009, at
8:00 a.m. U.S. Eastern Time (8:00 p.m. Beijing/Hong Kong time) following the
announcement. Listeners may access the call by dialing the following numbers:
United States toll free: 1-888-378-0337
Hong Kong toll free: 800-968-103
Northern China toll free: 10 800 712 0046
Southern China toll free: 10 800 120 0046
International: 1-719-325-2106
Listeners may access the replay through June 10, 2009, by dialing the following numbers:
United States toll free: 1-888-203-1112
International: 1-719-457-0820
Password: 8847791
An audio webcast of the call will also be available through the Company`s
website at www.tongjitang.com.
About Tongjitang Chinese Medicines Company
Tongjitang Chinese Medicines Company, through its operating subsidiaries
Tongjitang Pharmaceutical, Tongjitang Distribution, Tongjitang Chain Stores,
Guizhou Long-Life Pharmaceutical Company Limited, Qinghai Pulante and Anhui
Jingfang, is a vertically integrated and profitable specialty pharmaceutical
company focused on the development, manufacturing, marketing and selling of
modernized traditional Chinese medicine in China. Tongjitang`s principal
executive offices are located in Shenzhen, China.
Tongjitang`s flagship product, Xianling Gubao, is the leading traditional
Chinese medicine for the treatment of osteoporosis in China as measured by sales
in Renminbi. In addition to Xianling Gubao, the Company manufactures and markets
36 other modernized traditional Chinese medicine products and 37 western
medicines. Please visit www.tongjitang.com for more information.
ICR, Inc.
Ashley M. Ammon or Christine Duan
203-682-8200 (Investor Relations)
Copyright Business Wire 2009
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.
Follow Reuters